Pancreatic Cancer Research

ResearcherLyon 1 UniversitéActive in the last 2 years

Béatrice Fervers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3498-6499; OpenAlex author ID A5082672081. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Anthropometric traits, metabolic biomarkers, and pancreatic cancer risk: a causal mediation analysis in UK Biobank. Last author DOI 10.1038/s41416-026-03524-9↗
  2. A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Co-author DOI 10.3390/cancers13112565↗
  3. Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001654↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yixing Wu · 2 shared papers, 2020–2021 · strength 0.31
  2. Lingeng Lu · 2 shared papers, 2020–2021 · strength 0.31
  3. Amina Amadou Yacouba · 1 shared paper, 2026 · strength 0.26
  4. Michael Fred Leitzmann · 1 shared paper, 2026 · strength 0.26
  5. Hongmei Zeng · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.